Delivery Order SPE2DB24D8003-SPE2DB25FJUBP
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,987.39, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 2, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZNH, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,828.26 firm fixed-price delivery order is for the supply of 4567886888 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The $5,441.71 firm fixed-price contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.0.5ML pharmaceutical products. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $6,719.14 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999.00 as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,219.22, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, specifically ZEPBOUND 15 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of March 20, 2025. Dakota Drug, Inc. holds a significant single-award...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTTS, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,848.11 and a performance period extending through February 5, 2025. This contract is not set aside and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. is a...
This federal contract award, SPE2DB24D8003|SPE2DB25FJTPG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,266.30 firm fixed-price delivery order is for the provision of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is not associated with a set-aside program and has an ultimate completion date of January 6, 2025. Dakota Drug, Inc. is the prime contractor and has a significant single-award...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $4,704.09, is for the delivery of pharmaceutical products, specifically the drug Zepbound 5 mg/0.5 ml pen. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $9,080.31 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4559106710 MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract is part of the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. Dakota Drug, Inc. holds a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the purchase of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a total ceiling value of $15,933.58 and a period of performance through November 18, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V...